APA (7th ed.) Citation

J, B., A, S., KY, L., L, F., DD, F., A, E., & S, R. (2024). Circulating IL-17F, but not IL-17A, is elevated in severe COVID-19 and leads to an ERK1/2 and p38 MAPK-dependent increase in ICAM-1 cell surface expression and neutrophil adhesion on endothelial cells. Frontiers in immunology, 15, 1452788. https://doi.org/10.3389/fimmu.2024.1452788

Chicago Style (17th ed.) Citation

J, Bédard-Matteau, Soulé A, Liu KY, Fourcade L, Fraser DD, Emad A, and Rousseau S. "Circulating IL-17F, but Not IL-17A, Is Elevated in Severe COVID-19 and Leads to an ERK1/2 and P38 MAPK-dependent Increase in ICAM-1 Cell Surface Expression and Neutrophil Adhesion on Endothelial Cells." Frontiers in Immunology 15 (2024): 1452788. https://doi.org/10.3389/fimmu.2024.1452788.

MLA (9th ed.) Citation

J, Bédard-Matteau, et al. "Circulating IL-17F, but Not IL-17A, Is Elevated in Severe COVID-19 and Leads to an ERK1/2 and P38 MAPK-dependent Increase in ICAM-1 Cell Surface Expression and Neutrophil Adhesion on Endothelial Cells." Frontiers in Immunology, vol. 15, 2024, p. 1452788, https://doi.org/10.3389/fimmu.2024.1452788.